Neurocognition and Adaptive Functioning in the 22q11.2 Deletion Syndrome Model of Schizophrenia

被引:0
|
作者
Fiksinski, Ania [1 ]
Breetvelt, Elemi [2 ]
Vorstman, Jacob [3 ]
Lee, Erin [4 ]
Boot, Erik [4 ]
Butcher, Nancy [4 ]
Palmer, Lisa [4 ]
Chow, Eva [4 ]
Kahn, Rene [1 ]
Bassett, Anne [2 ]
机构
[1] Univ Med Ctr Utrecht, Utrecht, Netherlands
[2] Univ Toronto, Toronto Gen Hosp, Toronto, ON, Canada
[3] UMC Utrecht, Hosp Sick Children, Utrecht, Netherlands
[4] Univ Toronto, Toronto, ON, Canada
关键词
Adaptive Functioning; Neurocognition; Schizophrenia; 22q11DS; High-risk;
D O I
10.1016/j.biopsych.2018.02.821
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
F207
引用
收藏
页码:S319 / S319
页数:1
相关论文
共 50 条
  • [31] DNA methylation in 22q11.2 deletion syndrome and risk to develop schizophrenia
    Jiao, Chuan
    Demars, Fanny
    He, Qin
    Kebir, Oussama
    Tripathi, Anushree
    Turbe, Hugo
    Demily, Caroline
    Krebs, Marie-Odile
    Jay, Therese
    Chaumette, Boris
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 663 - 663
  • [32] Neuroimaging Correlates of 22q11.2 Deletion Syndrome: Implications for Schizophrenia Research
    Boot, E.
    van Amelsvoort, T. A. M. J.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2012, 12 (21) : 2303 - 2313
  • [33] Risk factors for schizophrenia and psychiatric treatments in 22q11.2 deletion syndrome
    Gothelf, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S118 - S118
  • [34] Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome
    Bassett, Anne S.
    Marshall, Christian R.
    Lionel, Anath C.
    Chow, Eva W. C.
    Scherer, Stephen W.
    HUMAN MOLECULAR GENETICS, 2008, 17 (24) : 4045 - 4053
  • [35] Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome
    Monks, Stephen
    Niarchou, Maria
    Davies, Aimee R.
    Walters, James T. R.
    Williams, Nigel
    Owen, Michael J.
    van den Bree, Marianne B. M.
    Murphy, Kieran C.
    SCHIZOPHRENIA RESEARCH, 2014, 153 (1-3) : 231 - 236
  • [36] SCHIZOPHRENIA POLYGENIC RISK SCORE ANALYSIS IN 22Q11.2 DELETION SYNDROME
    Monfeuga, Thomas
    Epstein, Michael P.
    Holleman, Aaron M.
    Cleynen, Isabelle
    Johnston, Henry
    Zhao, Yingjie
    McDonald-McGinn, Donna M.
    Gur, Raquel E.
    Warren, Stephen T.
    Vermeesch, Joris
    Emanuel, Beverly S.
    Morrow, Bernice E.
    Bassett, Anne S.
    Williams, Nigel
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : 1069 - 1070
  • [37] Neuropathological analysis of 22q11.2 deletion syndrome model mice
    Tanigaki, Kenji
    NEUROSCIENCE RESEARCH, 2011, 71 : E106 - E106
  • [38] Neuropathological analysis of 22q11.2 deletion syndrome model mice
    Toritsuka, Michihiro
    Kimoto, Sohei
    Muraki, Kazue
    Kishimoto, Toshifumi
    Tantgaki, Kenji
    NEUROSCIENCE RESEARCH, 2008, 61 : S129 - S129
  • [39] Hearing Loss in a Mouse Model of 22q11.2 Deletion Syndrome
    Fuchs, Jennifer C.
    Zinnamon, Fhatarah A.
    Taylor, Ruth R.
    Ivins, Sarah
    Scambler, Peter J.
    Forge, Andrew
    Tucker, Abigail S.
    Linden, Jennifer F.
    PLOS ONE, 2013, 8 (11):
  • [40] 22q11.2 Deletion Syndrome as a Human Model for Idiopathic Scoliosis
    de Reuver, Steven
    Homans, Jelle F.
    Schloesser, Tom P. C.
    Houben, Michiel L.
    Deeney, Vincent F. X.
    Crowley, Terrence B.
    Stuecker, Ralf
    Pasha, Saba
    Kruyt, Moyo C.
    McDonald-McGinn, Donna M.
    Castelein, Rene M.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)